Skip to main content
Premium Trial:

Request an Annual Quote

Epistem Taps India's Xcelris to Help Evaluate POC MDx Platform

Premium

Epistem and Xcelris said today that they are partnering to evaluate Epistem's PCR-based, point-of-care molecular testing device for the early detection of tuberculosis.

Epistem and Xcelris, an Indian genomics research and diagnostic testing firm, will evaluate Epistem's GeneDrive device as part of India's Revised National Tuberculosis Control Programme, initiated in 1997 to ensure the rapid diagnosis and treatment of TB patients.

Citing statistics from the World Health Organization, Epistem said that India has the highest number of TB sufferers in the world. Each year about 2 million people in India come down with TB with about half of the cases fatal.

In April, Manchester, UK-based Epistem said that had begun collaborating with undisclosed clinical labs and companies in the UK and US to beta test GeneDrive, a fully integrated, endpoint PCR-based platform that weighs just over one pound and has a footprint similar to that of a tablet computer (PCR Insider, 4/7/11).

Featuring push-button operation and integrated data analysis, the device also uses a thin-walled consumable cartridge and fast thermal cycling technology that is capable of performing about 30 PCR cycles in as little as 17 minutes.

Epistem said that GeneDrive's size, speed, and low cost — the company has said it can manufacture an instrument for about $400 with a $0.50 consumable cartridge — makes it conducive to use in remote locations.

The company had not previously disclosed other potential tests for GeneDrive, but this week said that the device can also be used to detect the causative agent of Dengue fever and several sexually transmitted diseases.

The TB evaluation program with Xcelris will continue through this year. Financial and other terms of the deal were not disclosed.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.